Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,040 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.
Tomioka N, Hatanaka KC, Okuyama D, Watanabe KI, Yamamoto M, Maeda H, Tachikawa H, Kuwahara S, Shimizu A, Suzuki H, Hatanaka Y, Takahashi M. Tomioka N, et al. Among authors: maeda h. Breast Cancer. 2023 May;30(3):497-505. doi: 10.1007/s12282-023-01442-9. Epub 2023 Mar 9. Breast Cancer. 2023. PMID: 36892732 Free PMC article.
Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.
Tomioka N, Hatanaka KC, Okuyama D, Watanabe KI, Yamamoto M, Maeda H, Tachikawa H, Kuwahara S, Shimizu A, Suzuki H, Hatanaka Y, Takahashi M. Tomioka N, et al. Among authors: maeda h. Breast Cancer. 2023 Jul;30(4):689-690. doi: 10.1007/s12282-023-01454-5. Breast Cancer. 2023. PMID: 37103743 Free PMC article. No abstract available.
BRAF V600E-mutated Colorectal Neuroendocrine Carcinoma Effectively Treated with a Chemotherapy Protocol for BRAF-mutated Metastatic Colorectal Cancer.
Owaki S, Mori Y, Nakai S, Maeda H, Imazu M, Tomita Y, Kanaiwa H, Yamaguchi A, Kitagawa M, Hirano A, Kimura Y, Tsuchida K, Kataoka H. Owaki S, et al. Among authors: maeda h. Intern Med. 2024 Jul 15;63(14):1995-1999. doi: 10.2169/internalmedicine.2870-23. Epub 2023 Nov 20. Intern Med. 2024. PMID: 37981300 Free PMC article.
Comparing cancer drug approval systems in the United States and Japan.
Kaneda Y, Maeda H, Ozaki A, Higuchi Y, Tanimoto T. Kaneda Y, et al. Among authors: maeda h. Health Sci Rep. 2023 May 10;6(5):e1265. doi: 10.1002/hsr2.1265. eCollection 2023 May. Health Sci Rep. 2023. PMID: 37181668 Free PMC article. No abstract available.
4,040 results